SAVSU Technologies has hitched its fortunes to the rapidly-emerging, personalized-medicine industry.
The Albuquerque startup, which launched in 2010, only began commercial operations last year. But its thermal shipping containers are now delivering frozen cells and genes to institutional customers on five different continents, providing a critical bridge for the emerging industry to bring new, cutting-edge therapies to market.
“Hundreds of companies and institutions are now using our product, from research universities, hospitals and clinics to some of today’s biggest pharmaceutical, biotechnology and specialty-shipping companies,” said SAVSU CEO Dana Barnard. “The only continents we’re not yet on is the Antarctica and Africa.”
That puts SAVSU, which stands for State of the Art Vaccine Storage Unit, on the ground floor of a nascent industry that many believe could fundamentally change how people fight disease.